Search

Your search keyword '"Hemagglutinins, Viral metabolism"' showing total 758 results

Search Constraints

Start Over You searched for: Descriptor "Hemagglutinins, Viral metabolism" Remove constraint Descriptor: "Hemagglutinins, Viral metabolism"
758 results on '"Hemagglutinins, Viral metabolism"'

Search Results

1. Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.

2. Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination.

3. Hemagglutinating properties of a Streptococcus gordonii strain expressing sialic acid-binding adhesin homolog with low binding site similarity to that of strain DL1.

4. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody.

5. Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin.

6. Reverse Genetics with a Full-Length Infectious cDNA Clone of Bovine Torovirus.

7. Synthetic O -Acetylated Sialosides and their Acetamido-deoxy Analogues as Probes for Coronaviral Hemagglutinin-esterase Recognition.

8. The role of glycosylation in the N-terminus of the hemagglutinin of a unique H4N2 with a natural polybasic cleavage site in virus fitness in vitro and in vivo .

9. Reversible O -Acetyl Migration within the Sialic Acid Side Chain and Its Influence on Protein Recognition.

10. TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.

11. Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.

12. Glycan remodeled erythrocytes facilitate antigenic characterization of recent A/H3N2 influenza viruses.

13. Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19.

14. How Influenza's Spike Motor Works.

15. Ygr125w/Vsb1-dependent accumulation of basic amino acids into vacuoles of Saccharomyces cerevisiae.

16. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.

17. Application of error-prone PCR to functionally probe the morbillivirus Haemagglutinin protein.

18. Tissue Microarrays to Visualize Influenza D Attachment to Host Receptors in the Respiratory Tract of Farm Animals.

19. In situ structure and organization of the influenza C virus surface glycoprotein.

20. Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation.

21. Subcellular localization of the porcine deltacoronavirus nucleocapsid protein.

22. Mucin-Inspired, High Molecular Weight Virus Binding Inhibitors Show Biphasic Binding Behavior to Influenza A Viruses.

23. Structure based virtual screening identifies small molecule effectors for the sialoglycan binding protein Hsa.

24. Molecular Characterization of Influenza C Viruses from Outbreaks in Hong Kong SAR, China.

25. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity.

26. Adaptation of influenza B virus by serial passage in human airway epithelial cells.

27. Cryo-EM structure of coronavirus-HKU1 haemagglutinin esterase reveals architectural changes arising from prolonged circulation in humans.

28. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.

29. Structural characteristics of measles virus entry.

30. Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.

31. Identification of amino acid residues involved in the interaction between peste-des-petits-ruminants virus haemagglutinin protein and cellular receptors.

32. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.

33. The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection.

34. Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates.

35. Hemagglutinin Inhibitors are Potential Future Anti-Influenza Drugs for Mono- and Combination Therapies.

36. Influenza A Virus Hemagglutinin-Neuraminidase-Receptor Balance: Preserving Virus Motility.

37. Specificity of Morbillivirus Hemagglutinins to Recognize SLAM of Different Species.

38. Productive replication of peste des petits ruminants virus Nigeria 75/1 vaccine strain in vero cells correlates with inefficiency of maturation of the viral fusion protein.

39. Molecular mechanism by which residues at position 481 and 546 of measles virus hemagglutinin protein define CD46 receptor binding using a molecular docking approach.

40. Hydrogen-Deuterium Exchange Supports Independent Membrane-Interfacial Fusion Peptide and Transmembrane Domains in Subunit 2 of Influenza Virus Hemagglutinin Protein, a Structured and Aqueous-Protected Connection between the Fusion Peptide and Soluble Ectodomain, and the Importance of Membrane Apposition by the Trimer-of-Hairpins Structure.

41. Higher levels of B-cell mutation in the early germinal centres of an inefficient secondary antibody response to a variant influenza haemagglutinin.

42. Topological Design of Star Glycopolymers for Controlling the Interaction with the Influenza Virus.

43. Influenza Hemagglutinin Modulates Phosphatidylinositol 4,5-Bisphosphate Membrane Clustering.

44. Development of a reverse genetics system for a feline panleukopenia virus.

45. KDELR2 Competes with Measles Virus Envelope Proteins for Cellular Chaperones Reducing Their Chaperone-Mediated Cell Surface Transport.

46. Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.

47. Aloe vera and its Components Inhibit Influenza A Virus-Induced Autophagy and Replication.

48. Virus-mimetic polymer nanoparticles displaying hemagglutinin as an adjuvant-free influenza vaccine.

49. The Stabilities of the Soluble Ectodomain and Fusion Peptide Hairpins of the Influenza Virus Hemagglutinin Subunit II Protein Are Positively Correlated with Membrane Fusion.

50. Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry.

Catalog

Books, media, physical & digital resources